Nathan D. Jorgensen - 01 Mar 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
01 Mar 2023
Transactions value $
-$34,768
Form type
4
Filing time
02 Mar 2023, 17:35:49
Previous filing
08 Feb 2023
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$34.8K -6.31K -3.92% $5.51 154K 01 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney